University of Wisconsin Foundation »

Janux Therapeutics shares owned by University of Wisconsin Foundation

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by University of Wisconsin Foundation from 13F filings

Historical chart of University of Wisconsin Foundation investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by University of Wisconsin Foundation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by University of Wisconsin Foundation

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.0M 362k 13.80

More positions owned by University of Wisconsin Foundation

Nu Hldgs Ord Shs Cl A (NU)
Pearl Diver Credit Company I Com Shs (PDCC)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vaxcyte (PCVX)
Dyne Therapeutics (DYN)
Janux Therapeutics (JANX)

View all positions for University of Wisconsin Foundation

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
State Street Corporation
Vanguard Group
Adage Capital Partners GP
Prosight Management
OrbiMed Advisors
TCG Crossover Management
Alyeska Investment Group
Geode Capital Management
Goldman Sachs Group
Woodline Partners
Logos Global Management

View all funds holding Janux Therapeutics